E-LIB Suche - Ergebnisse für: Morgenstern, D.A.

1

P904 Appendectomy for refractory ulcerative colitis: result..:

Adamou, A ; Bercher, M ; Iesalnieks, I...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1656-i1656 , 2024

Link: https://doi.org/10.1093/..

2

435 Keratinocyte differentiation state and the cutaneous in..:

Morgenstern, A. ; Peterson, L.F. ; Arnold, K..
Journal of Investigative Dermatology. 144 (2024) 8 - p. S75 , 2024

Link: https://doi.org/10.1016/..

3

EE1 Implementation of Guideline-Recommended Strategies for ..:

Ye, W. ; Jiang, X. ; Kuo, S....
Value in Health. 26 (2023) 6 - p. S60 , 2023

Link: https://doi.org/10.1016/..

4

129P Naxitamab efficacy in patients with refractory/relapse..:

Kushner, B. ; Mora, J. ; Chan, G....
Immuno-Oncology and Technology. 20 (2023) - p. 100601 , 2023

Link: https://doi.org/10.1016/..

5

EP04.05-07 Improved Efficiency with Lungflag vs Opportunist..:

Choman, E.N. ; Gould, M.K. ; Yang, P.-C..
Journal of Thoracic Oncology. 18 (2023) 11 - p. S467 , 2023

Link: https://doi.org/10.1016/..

6

109P Impact of anti-drug antibody (ADA) on naxitamab effica..:

Kushner, B. ; Chan, G.C. ; Morgenstern, D.A....
Immuno-Oncology and Technology. 16 (2022) - p. 100213 , 2022

Link: https://doi.org/10.1016/..

7

62MO Naxitamab pivotal clinical trial planned interim analy..:

Mora, J. ; Chan, G.C. ; Morgenstern, D.A....
Immuno-Oncology and Technology. 16 (2022) - p. 100167 , 2022

Link: https://doi.org/10.1016/..

8

P587 Disease severity in the INFLAMMATORY BOWEL DISEASES: D..:

Timmer, A ; de Sordi, D ; Neuser, J...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i524-i525 , 2022

Link: https://doi.org/10.1093/..

9

Thawing Yedoma permafrost is a neglected nitrous oxide sour..:

Marushchak, M. E. ; Kerttula, J. ; Diáková, K....
Nature Communications. 12 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

10

Central nervous system relapse in high-risk stage 4 neurobl..:

Berlanga, P. ; Pasqualini, C. ; Pötschger, U....
European Journal of Cancer. 144 (2021) - p. 1-8 , 2021

Link: https://doi.org/10.1016/..

11

Anti-tumor efficacy of a combination therapy with PD-L1 tar..:

Marotte, L ; Capitao, M ; Deleine, C...
OncoImmunology. 10 (2021) 1 - p. , 2021

Link: https://doi.org/10.1080/..

12

86 Hospitals Can't Do It Alone: Navigating Addiction Care a..:

Harrison, L. ; O'Neill, K. ; DeMasi, L....
Annals of Emergency Medicine. 76 (2020) 4 - p. S34 , 2020

Link: https://doi.org/10.1016/..

13

160 Trends of Reported Marijuana Use in a Pediatric Emergen..:

DeMasi, L. ; Harrison, L. ; Shekher-Kapoor, M....
Annals of Emergency Medicine. 76 (2020) 4 - p. S62-S63 , 2020

Link: https://doi.org/10.1016/..

14

Therapeutic efficacy and tolerability of [225Ac]Ac-DOTA-hG2..:

Merkx, R. ; Kip, A. ; Franssen, G.M....
European Urology Open Science. 19 (2020) - p. e1482 , 2020

Link: https://doi.org/10.1016/..

15

Targeted α therapy with 213Bi and 225Ac:

Kellerbauer, A ; Bruchertseifer, F ; Malmbeck, R.
Journal of Physics: Conference Series. 1643 (2020) 1 - p. 012205 , 2020

Link: https://doi.org/10.1088/..